TuHURA BIOSCIENCES, INC./NV: 10-Q filed 2020-02-13
What TuHURA BIOSCIENCES, INC./NV reported in its quarterly report filed 2020-02-13 (fiscal Q2 2020): 22 published measures, 67 facts as tagged in accession 0001213900-20-003470.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2020-02-13
- Fiscal period
- fiscal Q2 2020
- Accession
- 0001213900-20-003470 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All TuHURA BIOSCIENCES, INC./NV filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-12-31 | 6,508,067 | USD | |
| At 2019-06-30 | 4,037,255 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-12-31 | 1,027,425 | USD | |
| At 2019-06-30 | 2,069,725 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-12-31 | 5,480,642 | USD | |
| At 2019-09-30 | 7,024,914 | USD | |
| At 2019-06-30 | 1,967,530 | USD | |
| At 2018-12-31 | 2,769,264 | USD | |
| At 2018-09-30 | 3,670,546 | USD | |
| At 2018-06-30 | 5,435,223 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-12-31 | 6,348,038 | USD | |
| At 2019-06-30 | 3,718,758 | USD | |
| At 2018-12-31 | 3,702,902 | USD | |
| At 2018-06-30 | 5,971,995 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-10-01 to 2019-12-31 | -1,740,051 | USD | 92 |
| 2019-07-01 to 2019-12-31 | -3,345,922 | USD | 184 |
| 2018-10-01 to 2018-12-31 | -1,809,697 | USD | 92 |
| 2018-07-01 to 2018-12-31 | -3,801,501 | USD | 184 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-12-31 | -3,976,058 | USD | 184 |
| 2018-07-01 to 2018-12-31 | -3,049,876 | USD | 184 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-12-31 | 6,605,338 | USD | 184 |
| 2018-07-01 to 2018-12-31 | 780,783 | USD | 184 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-12-31 | -63,933,043 | USD | |
| At 2019-06-30 | -60,578,345 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-10-01 to 2019-12-31 | 11,407,744 | shares | 92 |
| 2019-07-01 to 2019-12-31 | 9,473,153 | shares | 184 |
| 2018-10-01 to 2018-12-31 | 2,424,222 | shares | 92 |
| 2018-07-01 to 2018-12-31 | 2,360,566 | shares | 184 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-10-01 to 2019-12-31 | 0.15 | USD/shares | 92 |
| 2019-07-01 to 2019-12-31 | 0.35 | USD/shares | 184 |
| 2018-10-01 to 2018-12-31 | 0.75 | USD/shares | 92 |
| 2018-07-01 to 2018-12-31 | 1.63 | USD/shares | 184 |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-12-31 | 210,837 | USD | 184 |
| 2018-07-01 to 2018-12-31 | 255,653 | USD | 184 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-12-31 | 6,501,607 | USD | |
| At 2019-06-30 | 4,025,193 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-12-31 | 6,460 | USD | |
| At 2019-06-30 | 12,062 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-10-01 to 2019-12-31 | 1,765,940 | USD | 92 |
| 2019-07-01 to 2019-12-31 | 3,401,043 | USD | 184 |
| 2018-10-01 to 2018-12-31 | 1,822,133 | USD | 92 |
| 2018-07-01 to 2018-12-31 | 3,827,723 | USD | 184 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-10-01 to 2019-12-31 | 712,193 | USD | 92 |
| 2019-07-01 to 2019-12-31 | 1,433,668 | USD | 184 |
| 2018-10-01 to 2018-12-31 | 947,249 | USD | 92 |
| 2018-07-01 to 2018-12-31 | 1,966,369 | USD | 184 |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-12-31 | 21,178 | USD | |
| At 2019-06-30 | 21,178 | USD |
Long-term debt
Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 76 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-10-01 to 2019-12-31 | -1,740,051 | USD | 92 |
| 2019-07-01 to 2019-09-30 | -1,605,871 | USD | 92 |
| 2018-10-01 to 2018-12-31 | -1,809,697 | USD | 92 |
| 2018-07-01 to 2018-09-30 | -1,991,804 | USD | 92 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-10-01 to 2019-12-31 | -1,742,603 | USD | 92 |
| 2019-07-01 to 2019-12-31 | -3,350,520 | USD | 184 |
| 2018-10-01 to 2018-12-31 | -1,825,887 | USD | 92 |
| 2018-07-01 to 2018-12-31 | -3,853,776 | USD | 184 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-10-01 to 2019-12-31 | 1,053,747 | USD | 92 |
| 2019-07-01 to 2019-12-31 | 1,967,375 | USD | 184 |
| 2018-10-01 to 2018-12-31 | 874,884 | USD | 92 |
| 2018-07-01 to 2018-12-31 | 1,861,354 | USD | 184 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-12-31 | 5,602 | USD | 184 |
| 2018-07-01 to 2018-12-31 | 10,746 | USD | 184 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-10-01 to 2019-12-31 | 25,889 | USD | 92 |
| 2019-07-01 to 2019-12-31 | 55,121 | USD | 184 |
| 2018-10-01 to 2018-12-31 | 12,436 | USD | 92 |
| 2018-07-01 to 2018-12-31 | 26,222 | USD | 184 |
Inspect the source
- Entity
- TuHURA BIOSCIENCES, INC./NV / CIK 0001498382
- Captured
- 2026-09-20T09:11:11.339Z
- SEC response SHA-256
cbfb2cda3307f7af300be1fc56e9d85ca5186f16e46a189d675574c95ee74f5c
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001498382.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))